Application of an artificial intelligence ensemble for detection of important secondary findings on lung ventilation and perfusion SPECT-CT

Abstract

RationaleSingle-photon-emission-computerized-tomography/computed-tomography(SPECT/CT) is commonly used for pulmonary disease. Scant work has been done to determine ability of AI for secondary findings using low-dose-CT(LDCT) attenuation correction series of SPECT/CT. Methods120 patients with ventilation-perfusion-SPECT/CT from 9/1/21–5/1/22 were included in this retrospective study. AI-RAD companion(VA10A,Siemens-Healthineers, Erlangen, Germany), an ensemble of deep-convolutional-neural-networks was evaluated for the detection of pulmonary nodules, coronary artery calcium, aortic ectasia/aneurysm, and vertebral height loss. Accuracy, sensitivity, specificity was measured for the outcomes. Inter-rater reliability were measured. Inter-rater reliability was measured using the intraclass correlation coefficient (ICC) by comparing the number of nodules identified by the AI to radiologist. ResultsOverall per-nodule accuracy, sensitivity, and specificity for detection of lung nodules were 0.678(95%CI 0.615–0.732), 0.956(95%CI 0.900–0.985), and 0.456(95%CI 0.376–0.543), respectively, with an intraclass correlation coefficient (ICC) between AI and radiologist of 0.78(95%CI 0.71–0.83). Overall per-patient accuracy for AI detection of coronary artery calcium, aortic ectasia/aneurysm, and vertebral height loss was 0.939(95%CI 0.878–0.975), 0.974(95%CI 0.925–0.995), and 0.857(95%CI 0.781–0.915), respectively. Sensitivity for coronary artery calcium, aortic ectasia/aneurysm, and vertebral height loss was 0.898(95%CI 0.778–0.966), 1 (95%CI 0.958–1), and 1 (95%CI 0.961–1), respectively. Specificity for coronary artery calcium, aortic ectasia/aneurysm, and vertebral height loss was 0.969(95% CI 0.893–0.996), 0.897 (95% CI 0.726–0.978), and 0.346 (95% CI 0.172–0.557), respectively. ConclusionAI ensemble was accurate for coronary artery calcium and aortic ectasia/aneurysm, while sensitive for aortic ectasia/aneurysm, lung nodules and vertebral height loss on LDCT attenuation correction series of SPECT/CT.